Jurgen Lasch

Title: Jurgen Lasch: Innovator in Gene Therapy

Introduction

Jurgen Lasch is a prominent inventor based in Halle, Germany. He has made significant contributions to the field of gene therapy, particularly through his innovative approaches to intracellular delivery of biologically active molecules. His work has the potential to impact the treatment of various diseases, showcasing the importance of advancements in medical technology.

Latest Patents

Jurgen Lasch holds 2 patents that focus on novel methods for gene therapy. His latest patents include "Materials and methods for intracellular delivery of biologically active molecules." This invention is particularly relevant in the area of gene therapy for diseases. It involves the creation of a novel non-viral vector that can bind to desired DNA, forming a combination useful for transfecting diseased mitochondria in human or animal cells. The non-viral vector comprises a dequalinium salt that undergoes standard liposome production procedures, resulting in a vector known as DQAsomes.

Career Highlights

Lasch is affiliated with the University of Florida Research Foundation Inc., where he continues to advance his research in gene therapy. His work is characterized by a commitment to developing innovative solutions that address complex medical challenges.

Collaborations

Throughout his career, Jurgen Lasch has collaborated with notable colleagues, including Jeffrey Allen Hughes and Volkmar Weissig. These collaborations have further enriched his research and contributed to the advancement of gene therapy technologies.

Conclusion

Jurgen Lasch's contributions to the field of gene therapy through his innovative patents and collaborations highlight the critical role of inventors in advancing medical science. His work continues to pave the way for new treatment options for various diseases.